about
Rational excipient selection for co-amorphous formulations.Stabilisation of an amorphous form of ROY through a predicted co-former interaction.Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations : Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li.Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study.Cryochemical Synthesis of Polymorphous Nanostructures of a Steroid Neurohormone.Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolitesCo-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution BehaviorsEngineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous MediumCo-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and HypercholesterolemiaProperties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
P2860
Q38856865-34C4073F-6B18-4A86-8067-75A688749822Q38876711-8C269B74-44FB-4C22-BB10-C552C99D37CDQ47656382-2FEA3509-E8C9-4F88-92C1-3BB2298F83C6Q47725213-D25196EA-D276-4A3F-8992-ECDBF06A6B5FQ48686819-4D581E06-BC14-4F85-846F-A271FA408610Q48898230-DCF64C5D-CC56-489B-9A9E-270564A63F3FQ57071123-4EF8A02C-8890-4611-B455-556C354B5F74Q57094720-8293928B-E951-4C1B-BF8C-BC7BDFCA9028Q57174036-DAADF00C-5D61-4720-8334-CA4FFA756D7DQ58691868-1FB259F8-854C-4C94-AC21-4482AA9D966DQ59234241-9EC72A46-8778-4CFF-AD4C-165196CF0E3A
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Recent advances in co-amorphous drug formulations.
@en
type
label
Recent advances in co-amorphous drug formulations.
@en
prefLabel
Recent advances in co-amorphous drug formulations.
@en
P2093
P50
P1476
Recent advances in co-amorphous drug formulations.
@en
P2093
Holger Grohganz
Korbinian Löbmann
Swapnil Jayant Dengale
P304
P356
10.1016/J.ADDR.2015.12.009
P407
P577
2016-01-21T00:00:00Z